Filtros de búsqueda

Lista de obras de Davide Croce

An update on integrase inhibitors: new opportunities for a personalized therapy? The NEXTaim Project

artículo científico publicado en 2015

Antiretroviral treatments' durability and costs: important elements in the choice of first-line therapy.

artículo científico publicado en 2016

Budget impact analysis of antiretroviral less drug regimen simplification in HIV-positive patients on the Italian National Health Service

artículo científico publicado en 2014

Budget impact analysis of the simplification to atazanavir + ritonavir + lamivudine dual therapy of HIV-positive patients receiving atazanavir-based triple therapies in Italy starting from data of the Atlas-M trial

artículo científico publicado en 2017

Correction: Cost-Utility Analysis of Lopinavir/Ritonavir versus Atazanavir + Ritonavir Administered as First-Line Therapy for the Treatment of HIV Infection in Italy: From Randomised Trial to Real World.

artículo científico publicado en 2014

Cost-effectiveness analysis of dolutegravir plus backbone compared with raltegravir plus backbone, darunavir+ritonavir plus backbone and efavirenz/tenofovir/emtricitabine in treatment naïve and experienced HIV-positive patients

artículo científico publicado en 2017

Cost-effectiveness analysis of the use of daclatasvir + sofosbuvir + ribavirin (16 weeks and 12 weeks) vs sofosbuvir + ribavirin (16 weeks and 24 weeks) for the treatment of cirrhotic patients affected with hepatitis C virus genotype 3 in Italy

artículo científico publicado en 2016

Cost-effectiveness of a successful schistosomiasis control programme in Cambodia (1995-2006).

artículo científico publicado en 2009

Cost-utility analysis of lopinavir/ritonavir versus atazanavir + ritonavir administered as first-line therapy for the treatment of HIV infection in Italy: from randomised trial to real world

artículo científico publicado en 2013

Cost-utility and budget impact analyses of the use of NEPA for chemotherapy-induced nausea and vomiting prophylaxis in Italy.

artículo científico publicado en 2017

Economic and organizational sustainability of a negative-pressure portable device for the prevention of surgical-site complications

artículo científico publicado en 2017

Financial and feasibility implications of the treatment of hepatitis C virus in Italy: scenarios and perspectives.

artículo científico publicado en 2016

HIV Clinical Pathway: A New Approach to Combine Guidelines and Sustainability of Anti-Retroviral Treatment in Italy

artículo científico publicado en 2016

Health technology assessment in the HIV setting: the case of monotherapy.

artículo científico publicado en 2014

Integrated care in the management of chronic diseases: an Italian perspective.

artículo científico publicado en 2016

Intraprocedural contrast-enhanced ultrasound (CEUS) in liver percutaneous radiofrequency ablation: clinical impact and health technology assessment.

artículo científico publicado en 2014

Introduction of concept of cost centre management in a public hospital in South Africa.

artículo científico publicado en 2010

Monocentric Analysis of the Effectiveness and Financial Consequences of the Use of Lenograstim versus Filgrastim for Mobilization of Peripheral Blood Progenitor Cells in Patients with Lymphoma and Myeloma Receiving Chemotherapy and Autologous Stem C

scientific article published on 02 April 2020

New Highly Active Antiretroviral drugs and generic drugs for the treatment of HIV infection: a budget impact analysis on the Italian National Health Service (Lombardy Region, Northern Italy)

artículo científico publicado en 2015

TECHNOLOGY ASSESSMENT IN HOSPITALS: LESSONS LEARNED FROM AN EMPIRICAL EXPERIMENT.

artículo científico publicado en 2017

The cost of HIV disease in Northern Italy: the payer's perspective

artículo científico publicado en 2011

The management of antiretroviral treatments in Europe: the Italian experience

artículo científico

Dominio Público Uruguay está sostenido por:

Acerca de Dominio Público Uruguay

Ayuda